-+ 0.00%
-+ 0.00%
-+ 0.00%

ARROWHEAD PHARMACEUTICALS - EUROPEAN COMMISSION DECISION ON REDEMPLO MARKETING AUTHORIZATION EXPECTED IN Q2 2026

Reuters·04/24/2026 10:39:08

Please log in to view news